Zhi Tong Cai Jing·2025-05-19 11:15Core Insights - Alibaba Health (00241) reported a revenue of RMB 30.598 billion for the fiscal year ending March 31, 2025, representing a year-on-year increase of 13.2% [1] - Adjusted net profit reached RMB 1.95 billion, up 35.6% year-on-year, while profit attributable to the parent company was RMB 1.432 billion, reflecting a significant increase of 62.14% [1] - The company experienced stable growth in its Tmall Health platform, with annual GMV maintaining robust growth and active user numbers continuing to rise [1] Revenue and Profitability - Total revenue for the reporting period was RMB 30.598 billion, marking a 13.2% increase year-on-year [1] - Net profit for the period was RMB 1.432 billion, showing a year-on-year growth of 62.2% [1] - Adjusted net profit amounted to RMB 1.95 billion, with an adjusted net profit margin increasing from 5.3% to 6.4% [1] Business Development - The Tmall Health platform's advertising business saw rapid growth, enhancing merchants' operational capabilities and brand service [1] - The company is actively exploring AI applications in the medical service sector to improve efficiency and process quality [1] User Engagement and Logistics - The effective GMV from online self-operated stores showed healthy growth, with active user numbers and self-operated membership continuing to rise [2] - The number of self-operated SKUs increased by 33.6% year-on-year to 1.23 million [2] - The company has optimized its pharmaceutical logistics network, maintaining high levels of next-day delivery service, which is expanding to cover 13 cities [2]